[1]
Prussick, R., Lebwohl, M., Gunn, N., Harris, S., Vittitow, J., Jacobson, A. and Israel, R.J. 2019. Patients With Psoriasis Treated With Brodalumab: A Pooled Post Hoc Analysis of a Marker of Liver Inflammation in Individuals With Potential Indicators of Early Nonalcoholic Fatty Liver Disease. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S20. DOI:https://doi.org/10.25251/skin.3.supp.20.